Subsets

Related by string. subset . subsets . Subset * * lymphocyte subsets . surgeons subsets *

Related by context. All words. (Click for frequent words.) 66 Polymorphism 63 Phenotypic 63 Immunomodulatory 63 Differentially 63 Transcription Factor 62 Hematopoietic Stem Cells 62 Brain Metastases 62 Signaling Pathways 62 Prognostic Factors 62 Sipuleucel T 62 DNA Methylation 62 Cardiotoxicity 62 Immunosuppression 61 DNA Polymerase 61 Chemokine Receptor 61 Genetic Variation 61 Hematopoietic 61 Mutational 61 Histologic 61 Kinase Inhibitors 61 Molecular Basis 61 Brain Wiring 61 Antigens 61 Neural Stem Cells 61 Tumor Suppressor 61 Androgen Receptor 61 Estrogen Receptor 61 Polymerase 61 Transcriptome 61 Gene Mutation 60 Progenitor Cells 60 Confocal Microscopy 60 Reproducible 60 Gene Variants 60 X Chromosome 60 Disease Progression 60 Adjuvant Chemotherapy 60 Nicotinic 60 Prostate Cancer Cells 60 Lymphocytes 60 Nucleotide 60 Breast Cancer Metastasis 60 Novel Inhibitor 60 Phenotypes 60 Hepatocytes 60 Mesenchymal Stem Cells 59 Leukemias 59 Epithelial 59 Transdermal Delivery 59 Systemic Delivery 59 Smooth Muscle 59 Lymphocyte 59 Dendritic Cells 59 Protein Synthesis 59 Allogeneic 59 Proteases 59 Phenotyping 59 Cytotoxic T 59 Antitumor 59 Clinical Outcome 59 Cytotoxicity 59 Tyrosine Kinase Inhibitor 59 Diabetic Nephropathy 59 Innate Immune 59 Epidermal Growth Factor Receptor 59 Genotypes 59 Anti Tumor Activity 59 Monoclonal 59 Inhibitory 59 Breast Tissue 59 Lesion 59 Mimetics 59 Urinary Incontinence 59 Immune Responses 59 Immune Cell 59 Histologically 59 Tumor Cells 59 Angiogenic 59 Skeletal Muscle 59 Gene Variation 59 Conjugated 59 costimulatory 59 Leukocyte 59 Tumor Necrosis Factor 59 AnaSpec Introduces 59 Malignancies 58 Circulating Tumor Cells 58 Patient Populations 58 urothelial carcinoma 58 Breast Cancer Cells 58 Oncogenic 58 Mouse Model 58 Stent Thrombosis 58 Fibroblast 58 Magnetic Nanoparticles 58 Cathepsin B 58 Inhaled Corticosteroids 58 Renal Function 58 Malignancy 58 Hepatocyte 58 Intracranial Aneurysms 58 Hippocampal 58 Carotid Endarterectomy 58 RNase L 58 Epitopes 58 Lymphoid 58 Aptamer 58 Antigenic 58 Protein Kinase 58 Antigen Specific 58 Blinatumomab 58 Signaling Pathway 58 metaplasia 58 Histone 58 extramedullary 58 druggable targets 58 Ligands 58 Dendritic cell 58 cytotoxicity assays 58 Severe Asthma 58 Pharmacodynamics 58 Autoimmune Disorders 58 Demonstrates Efficacy 58 Morphologic 58 Enzastaurin 58 Deforolimus 58 Anti Tumor 58 ErbB1 58 Synthetic Peptide 58 Phenotype 58 Quorum Sensing 58 Genetic Variant 58 Risk Stratification 58 Homology 58 Phosphorylation 58 Endothelial Cells 58 Macrophage 58 Urinary Catheter 58 Alleles 58 Secretion 58 Antiplatelet Therapy 58 Breast Tumors 58 Stress Hormone 58 Lung Tumors 58 Circadian Clock 58 Colon Polyps 58 Histopathologic 58 Polymorphisms 58 Adjuvant Breast Cancer 58 Cell Adhesion 58 Myocardial Ischemia 58 Analyte 58 Kinases 58 Effector 58 Inflammatory Pain 58 Single Nucleotide Polymorphisms 58 Targeted Therapy 58 Quantitation 58 Aromatase 58 Shows Promise Against 58 Cell Differentiation 58 Uric Acid 58 Neuroprotection 58 Telomere 57 Intravascular 57 Invasive Breast Cancer 57 Randomized Trials 57 TNF Alpha 57 Assay Kits 57 Diabetic Foot Ulcer 57 Inflammatory Markers 57 Fallopian Tube 57 Prostate Cancer Progression 57 Transfection 57 Peripheral Blood 57 transcranial Doppler ultrasound 57 Monocytes 57 Septic Shock 57 Nerve Cell 57 flavopiridol 57 Novel Method 57 clinico pathological 57 Insulin Sensitivity 57 metastatic neuroendocrine tumors 57 Bronchodilator 57 Autonomous Robots 57 Herpes Virus 57 Oropharyngeal 57 Cardiac Function 57 Protein Expression 57 Cancer Stem Cells 57 immunohistochemical analysis 57 Platelet Function 57 See CLINICAL PHARMACOLOGY 57 hepatoma 57 Fracture Risk 57 Abnormality 57 Neurotransmitter 57 Left Atrial 57 Aurora Kinase 57 Prostate Cancer Recurrence 57 Macroscopic 57 Infarct 57 Genetic Mutation 57 Senescence 57 Hypertrophy 57 Human Leukocyte Antigen 57 Intracerebral Hemorrhage 57 SSAO 57 Gender Differences 57 Diagnostic Tools 57 RFLP 57 OCT4 57 ABL1 57 Immunohistochemical 57 Hormone Refractory Prostate Cancer 57 annexin V 57 leiomyomas 57 Brain Scans 57 Effective Treatments 57 Diagnostic Criteria 57 azacytidine 57 Watchful Waiting 57 Mutagenesis 57 Pulmonary Vein Isolation 57 CHO K1 57 Mammalian 57 Adenoma 57 Non Inferiority 57 histological subtype 57 Carcinomas 57 Tumor Suppressor Gene 57 Pluripotent Stem Cells 57 Ischemic 57 gene locus 57 Tyrosine Kinase 57 HER2 HER3 57 Cytotoxic 57 Prostate Cancers 57 TLR antagonist 57 Imaging Techniques 57 Protein Linked 57 Pharmacologic 57 Beta Amyloid 57 somatic mutations 57 Kinase 57 Stem Cell Transplants 57 Platelet Derived Growth 57 Pharmacokinetics PK 57 Renal Cell Carcinoma 57 Protein Structure 57 Genetic Variations 57 Protein Biomarker 57 KRAS mutation 57 Genes Involved 57 Histone Deacetylase 56 Interpersonal Psychotherapy 56 Squalamine 56 Prognostic Significance 56 Hepatocellular Carcinoma 56 #S rRNA 56 Dehydrogenase 56 Nymox NX 56 Virus Infection 56 murine models 56 Gene Linked 56 Preclinical Study 56 Proteasome 56 serine protease 56 etiologic 56 Randomized Controlled Trials 56 Clinical Relevance 56 Lymphatic 56 Keratitis 56 Introgen ADVEXIN 56 Oral Cavity 56 K ras mutations 56 annexin 56 T Lymphocytes 56 Breast Cancers 56 Radiofrequency Ablation 56 Epithelium 56 Skin Lesions 56 Breast Cancer Recurrence 56 circadian genes 56 Virulence 56 Peritoneal 56 Ovarian Cancers 56 Personality Traits 56 multiplex PCR 56 ERK signaling 56 Long Term Outcomes 56 N glycan 56 Brain Aneurysms 56 DNA intercalator 56 Mitotic 56 Prolongs Survival 56 Muscle Cells 56 Ultrasound Imaging 56 Salivary 56 Oral Fingolimod 56 Genes Linked 56 Alkaline Phosphatase 56 Mesenchymal 56 Nilotinib 56 fosbretabulin 56 Motility 56 Main Outcome Measure 56 Breast Carcinoma 56 Incretin 56 Nedd4 56 transcriptomic 56 Spinal Fluid 56 p# biomarker 56 Enzyme Linked 56 Neuronal 56 Morpholino 56 Modifiable 56 Pooled Analysis 56 Subtypes 56 Randomized Clinical Trial 56 circulating endothelial 56 Bacterial Cell 56 Adenoviral 56 tumor subtypes 56 Neurogenesis 56 Ischaemic 56 CT Angiography 56 differential gene expression 56 Inactivation 56 Cardiovascular Disease Risk 56 G Protein Coupled 56 Novel Oral 56 Squamous Cell Carcinoma 56 Autoantibodies 56 Epitope 56 miRNA expression 56 Endothelial 56 Protein Structures 56 serum leptin 56 Treatment Regimen 56 Neurogenic 56 Stromal 56 Cardiomyocytes 56 Genetic Marker 56 Neoplasms 56 glycosyltransferase 56 histopathologic findings 56 RQ PCR 56 Disease Causing 56 Pathologic 56 Epithelial Cell 56 Placebo Controlled Trial 56 Receptor Antagonists 56 Angiographic 56 breast cancer subtypes 56 Galectin 56 gene amplification 56 Mouse Models 56 Modulates 56 QPCR 56 serine threonine kinase 56 Gene Silencing 56 Tumor Microenvironment 56 Induction Therapy 56 JAK STAT 56 KLF4 56 Glia 56 Treating Depression 56 subcellular localization 56 Adenomas 56 Testis 56 Thalamus 56 Cell Receptor 56 Coronary Angiography 56 Endothelium 56 EGIR 56 Chemotherapeutic Agents 56 Epileptic Seizures 56 Interferons 56 Catenin 56 Morphological 56 Nerve Cells 56 GPx 56 Depressive Symptoms 56 molecular abnormalities 56 logistic regression analyzes 56 Survivin 56 Coronary Arteries 56 microRNA expression 56 Germline 55 Intracellular 55 Progenitor Cell 55 Growth Hormone Deficiency 55 molecular biomarkers 55 VNTR 55 mediated apoptosis 55 HLA DR4 55 Preclinical Data 55 Liver Tumors 55 Molecular Mechanisms 55 #p# [003] 55 Sex Hormones 55 Proves Effective 55 Anti CD# Antibody 55 Immunologic 55 Conjugation 55 Glycoprotein 55 HepG2 cells 55 Synthase 55 Coronary CTA 55 Phospho 55 PhysioLab platform 55 Lentiviral 55 Insulin Resistance 55 Laryngeal Cancer 55 #S rRNA gene 55 Sexual Desire 55 Treatment Regimens 55 Antiangiogenic 55 Genetic Mutations 55 Artery Disease 55 Cannabinoid 55 Effectively Treats 55 Lymphocytic 55 Fibroblasts 55 Sonographic 55 Bone Marrow Cells 55 Nodule 55 Heart Failure Therapy 55 Therapeutic Efficacy 55 pancreatic adenocarcinoma 55 QRT PCR 55 CpG island 55 Nucleic acids 55 Chronic HCV 55 Figure S4 55 Contrast Agents 55 beta2 adrenergic receptor 55 Dose Response 55 RAV# 55 Metabolites 55 antiangiogenic agent 55 benign neoplasms 55 gefitinib Iressa 55 Tyrosine 55 Prostate Biopsy 55 Immunohistochemical analysis 55 Epidermal 55 Transcriptional 55 FGFR3 55 Dopaminergic 55 Migraine Treatment 55 Colorectal Cancer Patients 55 Bile Acid 55 estrogen estradiol 55 QTL mapping 55 chromosome #q#.# [002] 55 HLA DR 55 Inflammatory Response 55 Reprogrammed 55 EGFR HER2 55 transgenic mouse models 55 Viral Infections 55 Reduced Risk 55 Vertebral Fractures 55 Antidepressants Linked 55 astrocytic 55 CCL# 55 K#R [002] 55 Virus Linked 55 Histological 55 Data Extraction 55 Therapy Shows Promise 55 Skin Cancers 55 Neuroanatomy 55 Kidney Function 55 NSCLC tumors 55 Kinase Inhibitor 55 RNA Interference 55 Placebo Controlled Study 55 Sentinel Lymph Node Biopsy 55 RT qPCR 55 Erythropoietic 55 DNA methylation patterns 55 Oligonucleotides 55 Self Assembling 55 PTPN# 55 Object Recognition 55 Lung Cancer Risk 55 Atherosclerotic 55 mouse neural stem 55 TRAIL receptors 55 melanocytic nevi 55 Treating Chronic 55 Therapeutic Effects 55 Drug Eluting 55 Leukotriene 55 Amino Acid 55 Myeloperoxidase 55 Novel Compound 55 pharmacodynamic endpoints 55 Cognitive Impairment 55 GSTP1 55 Scale Revised 55 Neuroprotective 55 Modulating 55 HDAC Inhibitor 55 Beta Blocker 55 Differential Diagnosis 55 Subtype 55 Cytogenetic 55 Skin Cells 55 Clinical Trial Data 55 Bioavailability 55 Macrocyclic 55 benzimidazole 55 Apoptotic 55 Dilated Cardiomyopathy 55 Beta Blockers 55 Potent Inhibitor 55 ANCOVA 55 Catheter Ablation 55 Secretory 55 T lymphocyte 55 Glycosylation 55 Choroidal Neovascularization 55 tumor xenograft models 55 Schizophrenia Treatment 55 Inhibits 55 Protein Kinase C 55 Suicidal Ideation 55 Multiplexed 55 Calcification 55 Immune Cells 55 Bosutinib 55 Hepatocellular 55 Wwox 55 Overactive Bladder 55 Lipoprotein 55 CXCR4 expression 54 KRAS gene mutations 54 Lymph Nodes 54 R#W [002] 54 immunofluorescence microscopy 54 beta1 54 immunostaining 54 Panic Disorder 54 antisense inhibitor 54 Androgen 54 Structure Function 54 Upregulation 54 uricase 54 Squamous 54 Immunostimulatory 54 Dissociation 54 BioMAP 54 Solid Tumors 54 Highly Potent 54 Device Helps 54 tyrosine phosphorylation 54 Ischemic Stroke 54 CYP#C# gene 54 Optical Coherence Tomography 54 IFN α 54 Male Contraceptive 54 microarray experiments 54 androgen receptor AR 54 histologic subtypes 54 Electrical Stimulation 54 homodimer 54 antiproliferative activity 54 Viral Suppression 54 genes encode proteins 54 Autoimmune Disease 54 Electrophoresis 54 microtubule targeting 54 Cell Proliferation 54 Ovarian Cancer Risk 54 Cigarette Smoke 54 Analogs 54 Gastric Cancer 54 Temsirolimus 54 cAMP signaling 54 Respiratory Virus 54 Protein Function 54 pharmacodynamic parameters 54 Drug Shows Promise 54 BERKELEY CA UroToday.com 54 Analytical Tool 54 Vasculature 54 Glial 54 Prostatic 54 transmembrane protein 54 Sentinel Lymph Node 54 Hematologic 54 microsatellite instability 54 FDG PET imaging 54 Genital Herpes 54 Suboptimal 54 triiodothyronine 54 Genetic Predisposition 54 mRNA expression 54 Localized Prostate Cancer 54 fluorogenic 54 Estrogen Therapy 54 Heterogeneity 54 Critically Ill Patients 54 Carotid 54 florbetaben 54 Gram Negative 54 Methylation 54 Myocardial Perfusion 54 SNP rs# [001] 54 Left Ventricular 54 Appears Safe 54 Lymph Node 54 Lung Cancer Diagnosis 54 Breast Ovarian Cancer 54 Mammographic 54 #S rDNA 54 Male Pattern Baldness 54 Genes Associated 54 Histopathological 54 Rheumatoid Arthritis Patients 54 cDNAs 54 Predisposition 54 Diabetic Neuropathy 54 renal cortical 54 Lipid Levels 54 Crystallographic 54 flow cytometric analysis 54 Hepatic Encephalopathy 54 Cinacalcet 54 Cardiac Arrhythmias 54 CD3 + 54 IL#B 54 mucinous 54 Sleep Duration 54 mutational analysis 54 Allogeneic Stem 54 Secondary efficacy endpoints 54 Inflammatory Diseases 54 Antiviral Therapy 54 Breast Cancer Stem Cells 54 Antipsychotic Drug 54 Cognitive Problems 54 tissue microarrays 54 Therapeutic Vaccine 54 activating mutation 54 Combo Therapy 54 c KIT 54 NMDA Receptor 54 peptide conjugated 54 Integrin 54 Aplidin R 54 Neurotoxicity 54 Hormonal Therapy 54 Rearrangements 54 Antidepressant Treatment 54 Protein Interactions 54 Chronic Pelvic Pain 54 enzyme immunoassay EIA 54 5alpha reductase 54 Tumor Response 54 ELISA assays 54 Autoimmune Diseases 54 matrix metalloproteases 54 Microstructural 54 Sleep Disturbances 54 Stem Cell Differentiation 54 Acne Scars 54 Reflux Disease 54 GLUT4 54 PCR primers 54 anterior pituitary 54 adenocarcinomas 54 downstream effector 54 Cancer Cells 54 EphB4 54 Cholinesterase Inhibitors 54 Treatment Approaches 54 Invariant 54 PI3K/mTOR 54 Superoxide 54 Vitro Activity 54 Transgenic Mice 54 Prospective Randomized Trial 54 Safinamide 54 Endothelial Function 54 differentially expressed genes 54 Gut Bacteria 54 Pertuzumab 54 RNA polymerases 54 pDC 54 Papillary 54 Dictyostelium discoideum 54 Adrenal 54 Phosphatase 54 Thyroid Hormone 54 agarose gel electrophoresis 54 Cerebral Cortex 54 Malformations 54 Gene Mutations 54 protein tyrosine phosphatases 54 Protein Interaction 54 Treated Patients 54 Tubulin 54 Prostate Cancer Outcomes 54 KRAS oncogene 54 constitutively expressed 54 Intervention Trial 54 APiX 54 Human Neural Stem 54 Medication Adherence 54 Meta analyzes 54 Huntingtin 54 Anticoagulant 54 JAK Inhibitor 54 Practice Patterns 54 Relieve Pain 54 intestinal permeability 54 Mucosal 54 Microarray Analysis 54 Sjögren syndrome 54 Occlusion 54 CD8 + 54 cDNA libraries 54 microarray gene expression 54 human leukocyte antigen HLA 54 Prognostic Value 54 Gleevec resistant 54 Lowers Blood Pressure 54 Subset 54 activatable 54 Anthracycline 54 variant allele 54 Double Blind Randomized 54 Dynamic Light Scattering 54 Hypoxia Inducible Factor 54 Immun 54 Genotypic 54 exploratory endpoints 54 Culturing 54 RNAi Therapeutic 54 Ejaculation 54 Protease Inhibitors 54 Intracerebral 54 Gene Variant 54 Improves Survival 54 Coronary Artery 54 Surgical Procedures 54 Carotid Stenting 54 Oncolytic 54 Blood Stem Cells 54 Aggressive Prostate Cancer 54 immunocompetent 54 Ectopic 54 Orally Active 54 genes CYP#C# 54 JAK2 enzyme 54 radiolabeled antibodies 54 Supplemental Figure 54 Hormone Replacement 54 Predict Prostate Cancer 54 Predict Breast Cancer 54 tumor subtype 54 Improves Outcomes 54 Imatinib mesylate 54 Imaging Technique 54 Neuroprotective Effects 54 BRCA1 BRCA2 54 Analytical Method 54 vitro assay 54 pancreatic ductal adenocarcinoma 54 Organ Rejection 54 Patients Treated With 54 Situ Hybridization 53 Exome 53 Genetic Markers 53 neuropathologic 53 Molecular Mechanism 53 susceptibility loci 53 TNM staging 53 Microtubule 53 JAK2 V#F 53 Epstein Barr Virus EBV 53 ribosomal protein 53 Treatment Outcome 53 hybridoma 53 immunoregulatory 53 soluble receptor 53 selective inhibition 53 Metastases 53 Comorbidities 53 Cancer Treatments 53 Placebo Effect 53 Ankle Sprains 53 Yeast Infections 53 Investigational Agent 53 Stent Restenosis 53 secretory pathway 53 Single Molecules 53 Treatment Algorithm 53 Cerebellar 53 Osteoporosis Drugs 53 T#I [002] 53 IgM antibody 53 Response Systems IVRS 53 Adult Stem Cell Therapy 53 cDNA microarray 53 Lipolysis 53 luciferase reporter 53 Cytoplasmic 53 Infectivity 53 ECG gated 53 Glucocorticoid 53 Replacement Therapy 53 Elderly Patients 53 Muscarinic 53 cRNA 53 Fc gamma receptor 53 Breast Density 53 CD4 + CD# 53 AT1R 53 Visual Perception 53 clinicopathologic 53 SensoLyte ® 53 SURVEYOR Nuclease 53 Prostate Cancer Risk 53 flow cytometric 53 genomic alterations 53 Plasmid DNA 53 Regimens 53 T#M 53 Western blotting 53 accumulate preferentially 53 cisplatin resistant 53 Analogues 53 Anthrax Toxin 53 Often Misdiagnosed 53 Protease 53 mononuclear 53 Genes Influence 53 Chronic Rhinosinusitis 53 oligodendrogliomas 53 Metastatic 53 transcriptional profiling 53 Hypothalamic 53 Rab5 53 genes differentially expressed 53 Biosynthesis 53 constitutively active 53 adoptive immunotherapy 53 Vps# 53 Fast Fourier Transform 53 BCL#A 53 Dasatinib 53 File Inclusion Vulnerabilities 53 Menopausal Women 53 Coronary Artery Bypass Graft 53 inferential statistics 53 PI3K Akt 53 coding exons 53 CCX# 53 Gastrointestinal Stromal Tumors 53 ghrelin agonist 53 Systemic Sclerosis 53 intercellular signaling 53 Dalbavancin 53 Leukemia Cells 53 E3 ligase 53 Randomized Study 53 Dystrophin 53 tumor specific antigen 53 Evaluable 53 Malaria Parasite 53 HDACi 53 morphological traits 53 Treatment Naive HIV 53 Replicates 53 peptide antigens 53 pleiotropic effects 53 Nonalcoholic Fatty Liver Disease 53 adipogenic 53 VKORC1 53 Ventricular Arrhythmias 53 Therapy Improves 53 Nucleic Acid 53 Autologous 53 Tumor Cell 53 Solubility 53 Increased Mortality 53 hypomethylation 53 Nerve Stimulation 53 Inflammatory Arthritis 53 Autologous Stem Cell Transplantation 53 Orthostatic Hypotension 53 Radiation Induced 53 multicenter randomized controlled 53 Dissections 53 Remote SQL Query 53 HCT# 53 VSV G 53 Novel Therapeutic 53 RECIST Response Evaluation Criteria 53 Scintigraphy 53 protein tyrosine phosphatase 53 Fatty Liver 53 Whole Genome Sequencing 53 Sequencing Systems 53 Controlled Trial 53 kinase inhibition 53 Tiotropium 53 Protein Folding 53 replicase 53 Ribosomal 53 MDR1 53 Mammary 53 Less Invasive 53 protein isoforms 53 ChIP Seq 53 Adverse Event 53 histopathologic 53 Fibroblast Growth Factor Receptor 53 Y Chromosome 53 missense mutations 53 p# p# 53 Viral Load 53 immunoconjugate 53 Activating mutations 53 PC# cells 53 Prostate Cancer Detection 53 mutational status 53 cell adhesion molecule 53 Ferritin 53 Endpoints 53 Checksum 53 Small Molecule 53 ALK mutations 53 Pediatric Patients 53 Esophageal 53 Blood Vessels 53 Minimally Invasive Treatment 53 Polymerase Inhibitor 53 intratumoral injection 53 Chronic Heart Failure 53 Correlates 53 Tumor Angiogenesis 53 FDG-PET/CT 53 Premature Aging 53 Childhood Vaccinations 53 CHD5 53 Percutaneous Tibial Nerve Stimulation 53 Cysteine 53 Gas Chromatography 53 D Dimer 53 Translocation 53 Nonspecific 53 Chronic Constipation 53 EGF receptors 53 prognostic variables 53 direct thrombin inhibitors 53 Low Incidence 53 delipidation 53 Late Breaker 53 Fungal Infections 53 Brain Derived Neurotrophic 53 RNA seq 53 Therapy Reduces 53 antiproliferative effects 53 Ligation 53 Phase 2a Trial 53 MLH1 53 transfection efficiency 53 Liver Cells 53 adducts 53 ventricular myocardium 53 aT cell 53 humoral responses 53 alternatively spliced 53 Mutation Analysis 53 mediated autoimmune diseases 53 Detect Cancer 53 Patency 53 AFLP 53 FLT3 53 S#P# 53 Blocked Arteries 53 baseline LDH 53 Retroviral 53 electrophysiologic 53 surgically resected 53 #:#-# [033] 53 lymphoid cells 53 single stranded oligonucleotides 53 Renal Cell Cancer 53 lysophosphatidic acid 53 ligand receptor

Back to home page